BMY
60
2
NVDA
56
-4
CAH
48
-5
PVH
62
5
MET
72
5
HCP
66
8
YUM
47
3
VZ
50
3
M
37
12
ROP
62
3
PGR
65
2
HST
49
-9
AA
48
-12
BSX
67
-3
ACN
52
3
CTSH
56
2
SYK
64
-4
EXC
53
-3
PEP
48
6
XYL
49
4
BMY
60
2
NVDA
56
-4
CAH
48
-5
PVH
62
5
MET
72
5
HCP
66
8
YUM
47
3
VZ
50
3
M
37
12
ROP
62
3
PGR
65
2
HST
49
-9
AA
48
-12
BSX
67
-3
ACN
52
3
CTSH
56
2
SYK
64
-4
EXC
53
-3
PEP
48
6
XYL
49
4
Financhill
Back

Corbus Pharmaceuticals Holdings Vs. Perspective Therapeutics Industry Stock Comparison

Sell
45

CRBP
Corbus Pharmaceuticals Holdings

Last Price:
17.45
Seasonality Move:
53.7%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.49
Seasonality Move:
34.33%
Sell
45
Corbus Pharmaceuticals Holdings (CRBP) is a Sell

Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?

  • The current Corbus Pharmaceuticals Holdings [CRBP] share price is $17.47. The Score for CRBP is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • CRBP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.47. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CRBP Stock Price Chart

What is Corbus Pharmaceuticals Holdings's stock price today?

  • The Corbus Pharmaceuticals Holdings share price today is $17.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRBP is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRBP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.44 Sell
Relative Strength Index (14 RSI): 42.37 Sell
Chaikin Money Flow: 98042 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.34 - 18.28) Buy
Bollinger Bands (100): (20.01 - 57.17) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.06 Sell
Relative Strength Index (14 RSI): 14.31 Sell
Chaikin Money Flow: 5909257 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.39 - 12.93) Sell
Bollinger Bands (100): (10.25 - 14.79) Sell

CRBP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.99 Buy
20-day SMA: 17.41 Buy
50-day SMA: 21.67 Sell
200-day SMA: 38.82 Sell
8-day EMA: 17.08 Buy
20-day EMA: 17.82 Sell
50-day EMA: 23.71 Sell
200-day EMA: 32 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.64 Sell
20-day SMA: 9.7 Sell
50-day SMA: 11.58 Sell
200-day SMA: 12.72 Sell
8-day EMA: 6.25 Sell
20-day EMA: 8.74 Sell
50-day EMA: 10.88 Sell
200-day EMA: 11.36 Sell

Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.66 per share, and a decrease next year of $1.27 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Corbus Pharmaceuticals Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):